EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157

Leah Holm-Mercer iD, Tze How Mok, Danielle Sequeira iD, Thomas Coysh iD, Peter Rudge, Hawraman Ramadan, Lee Darwent, Tracy Campbell, Thomas Murphy, Colin Smith, Diane Ritchie, Sebastian Brandner und 3 weitere

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251351182 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Leah Holm-Mercer und 14 weiteren Autor:innen. Beteiligte Einrichtung: MRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College London, London, UK. Hauptthemen laut MEDLINE: Prion Proteins, Frameshift Mutation, Prion Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIHR Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

PrP systemic amyloidosis is increasingly recognized as a novel inherited prion disease (IPD) syndrome caused by PRNP C-terminal truncating mutations. As well as systemic manifestations they cause gradually progressive cognitive impairment with neurofibrillary tangle pathology which can be mistaken for Alzheimer's disease (AD).

Objective

We describe the clinical, biomarker and neuropathological features of a novel frameshift mutation of PRNP resulting in protein truncation at codon 157.

Methods

The clinical phenotype and biomarker findings, including plasma biomarkers measured using Single Molecule Array (SiMOA) technology are reported for affected living individuals, with neuropathological examination available for the index case.

Results

The Y157X PRNP mutation has resulted in a phenotype of gradually progressive cognitive decline, peripheral sensory and autonomic polyneuropathy, and gastrointestinal symptoms, with one case presenting with recurrent episodes of nausea, vomiting and electrolyte derangement requiring intensive care unit admission. Plasma biomarkers revealed an AD-like pattern with raised neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP) and phospho-tau 181 (P-tau 181) in affected individuals. On neuropathological examination there was PrP-cerebral amyloid angiopathy (CAA) and neurofibrillary tau pathology.

Conclusions

We present the clinical, biomarker and pathological findings on investigation of this family and provide further evidence for the association of truncation mutations with PrP systemic amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prion ProteinsFrameshift MutationPrion DiseasesHumansMaleFemaleMiddle AgedCodonBiomarkersBrainAged

Stichwörter der Autor:innen

Alzheimer's diseasecerebral amyloid angiopathyframeshift mutationneurofibrillary tanglesprion diseases

Substanzen

Prion ProteinsPRNP protein, humanCodonBiomarkers

Autor:innen und Institutionen

  • MRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College London, London, UK.
  • NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary, Bradford, UK.
  • Academic Department of Neuropathology, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Division of Neuropathology, National Hospital for Neurology and Neurosurgery, London, UK.

ORCID-Profile: Leah Holm-Mercer, Danielle Sequeira, Thomas Coysh

Förderung

  • Medical Research Council
  • NIHR Biomedical Research Centre

Zitieren

APA

Holm-Mercer, L., Mok, T. H., Sequeira, D., Coysh, T., Rudge, P., Ramadan, H., Darwent, L., Campbell, T., Murphy, T., Smith, C., Ritchie, D., Brandner, S., Jaunmuktane, Z., Collinge, J., & Mead, S. (2025). Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251351182

Vancouver

Holm-Mercer L, Mok TH, Sequeira D, Coysh T, Rudge P, Ramadan H, et al. Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251351182

BibTeX
@article{HolmMercer2025,
  author = {Holm-Mercer, Leah and Mok, Tze How and Sequeira, Danielle and Coysh, Thomas and Rudge, Peter and Ramadan, Hawraman and Darwent, Lee and Campbell, Tracy and Murphy, Thomas and Smith, Colin and Ritchie, Diane and Brandner, Sebastian and Jaunmuktane, Zane and Collinge, John and Mead, Simon},
  title = {Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251351182}
}
Kostenlos starten →